• Filing Date: 2013-06-21
  • Form Type: 10-K
  • Description: Annual report
v2.4.0.6
Document and Entity Information (USD $)
12 Months Ended
Dec. 31, 2012
Jun. 19, 2013
Jun. 30, 2012
Document Information [Line Items]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2012    
Document Fiscal Year Focus 2012    
Document Fiscal Period Focus FY    
Trading Symbol NLTX    
Entity Registrant Name Nile Therapeutics, Inc.    
Entity Central Index Key 0001133869    
Current Fiscal Year End Date --12-31    
Entity Filer Category Smaller Reporting Company    
Entity Common Stock Shares Outstanding   43,062,231  
Entity Well-Known Seasoned Issuer No    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Public Float     $ 3,763,041